CellCentric raises $220M to get multiple myeloma pill to market

Will West, CellCentric CEO May 6, 2026 07:00 AM EDT FinancingStartups Cell­Cen­tric rais­es $220M to get mul­ti­ple myelo­ma pill to mar­ket Kyle LaHucik Biotech Correspondent Cell­Cen­tric has reeled in a mas­sive fund to help it ad­dress mul­ti­ple myelo­ma pa­tients who have ex­haust­ed all oth­er treat­ment op­tions. The 22-year-old transat­lantic biotech … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER